Advertisement
Screener

CRONOS GROUP INC. (CRON) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Operating Expenses

CRONOS GROUP INC. (CRON) reported Operating Expenses of $21.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-06

  • CRONOS GROUP INC. operating expenses for the quarter ending 2026-06-30 was $21.05M, a 6.15% increase year-over-year.
  • CRONOS GROUP INC. operating expenses for the quarter ending 2026-03-31 was $20.99M, a 17.86% increase year-over-year.
  • CRONOS GROUP INC. operating expenses for the quarter ending 2025-12-31 was $23.68M, a 6.82% increase year-over-year.
  • CRONOS GROUP INC. operating expenses for the quarter ending 2025-09-30 was $18.84M, a 49.46% decline year-over-year.
  • CRONOS GROUP INC. operating expenses for fiscal 2025 was $80.15M, a 21.21% decline from fiscal 2024.
  • CRONOS GROUP INC. operating expenses for fiscal 2024 was $101.73M, a 5.19% increase from fiscal 2023.
  • CRONOS GROUP INC. operating expenses for fiscal 2023 was $96.71M, a 23.77% decline from fiscal 2022.
  • CRONOS GROUP INC. operating expenses for fiscal 2022 was $126.86M, a 53.76% decline from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-30$21.05M
10-Q · filed 2026-08-06
$42.03M
10-Q · filed 2026-08-06
$65.72M
derived: sum of 3 quarters · filed 2026-08-06
$84.55M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$20.99M
10-Q · filed 2026-05-11
$44.67M
derived: sum of 2 quarters · filed 2026-05-11
$63.51M
derived: sum of 3 quarters · filed 2026-05-11
$83.33M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$23.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$42.52M
derived: sum of 2 quarters · filed 2026-02-26
$62.35M
derived: sum of 3 quarters · filed 2026-08-06
$80.15M
10-K · filed 2026-02-26
2025-09-30$18.84M
10-Q · filed 2025-11-06
$38.66M
derived: sum of 2 quarters · filed 2026-08-06
$56.47M
10-Q · filed 2025-11-06
$78.64M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$19.83M
10-Q · filed 2026-08-06
$37.63M
10-Q · filed 2026-08-06
$59.81M
derived: sum of 3 quarters · filed 2026-08-06
$97.07M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$17.81M
10-Q · filed 2026-05-11
$39.98M
derived: sum of 2 quarters · filed 2026-05-11
$77.24M
derived: sum of 3 quarters · filed 2026-05-11
$99.10M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$22.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$59.44M
derived: sum of 2 quarters · filed 2026-02-26
$81.30M
derived: sum of 3 quarters · filed 2026-02-26
$101.73M
10-K · filed 2026-02-26
2024-09-30$37.27M
10-Q · filed 2025-11-06
$59.12M
derived: sum of 2 quarters · filed 2025-11-06
$79.56M
10-Q · filed 2025-11-06
$103.10M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$21.86M
10-Q · filed 2025-08-07
$42.29M
10-Q · filed 2025-08-07
$65.84M
derived: sum of 3 quarters · filed 2026-02-26
$91.58M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$20.43M
10-Q · filed 2025-05-08
$43.98M
derived: sum of 2 quarters · filed 2026-02-26
$69.72M
derived: sum of 3 quarters · filed 2026-02-26
$93.44M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$23.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$49.29M
derived: sum of 2 quarters · filed 2026-02-26
$73.01M
derived: sum of 3 quarters · filed 2026-02-26
$96.71M
10-K · filed 2026-02-26
2023-09-30$25.75M
10-Q · filed 2024-11-12
$49.46M
derived: sum of 2 quarters · filed 2024-11-12
$73.16M
10-Q · filed 2024-11-12
$101.45M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$23.72M
10-Q · filed 2024-08-08
$47.41M
10-Q · filed 2024-08-08
$75.71M
derived: sum of 3 quarters · filed 2025-02-27
$106.19M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$23.70M
10-Q · filed 2024-05-09
$24.38M
10-Q · filed 2023-05-09
$51.99M
derived: sum of 2 quarters · filed 2025-02-27
$82.47M
derived: sum of 3 quarters · filed 2025-02-27
$112.09M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$28.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$58.77M
derived: sum of 2 quarters · filed 2025-02-27
$88.39M
derived: sum of 3 quarters · filed 2025-02-27
$126.86M
10-K · filed 2025-02-27
$136.81M
10-K · filed 2023-02-28
2022-09-30$30.48M
10-Q · filed 2023-11-08
$32.16M
10-Q · filed 2022-11-07
$60.10M
derived: sum of 2 quarters · filed 2023-11-08
$98.57M
10-Q · filed 2023-11-08
$107.32M
10-Q · filed 2022-11-07
-$1.03M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$29.62M
10-Q · filed 2023-08-08
$32.19M
10-Q · filed 2022-08-09
$68.09M
10-Q · filed 2023-08-08
$75.16M
10-Q · filed 2022-08-09
-$31.51M
derived: sum of 3 quarters · filed 2024-02-29
$24.18M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$42.98M
10-Q · filed 2023-05-09
-$61.13M
derived: sum of 2 quarters · filed 2024-02-29
-$5.45M
derived: sum of 3 quarters · filed 2024-02-29
$275.11M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$104.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$48.42M
derived: sum of 2 quarters · filed 2024-02-29
$232.14M
derived: sum of 3 quarters · filed 2024-02-29
$274.38M
10-K · filed 2024-02-29
$543.06M
10-K · filed 2022-03-01
2021-09-30$55.68M
10-Q · filed 2022-11-07
$336.25M
derived: sum of 2 quarters · filed 2022-11-07
$378.48M
10-Q · filed 2022-11-07
$422.03M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$280.56M
10-Q · filed 2022-08-09
$44.43M
10-Q · filed 2021-08-06
$322.80M
10-Q · filed 2022-08-09
$84.93M
10-Q · filed 2021-08-06
$366.35M
derived: sum of 3 quarters · filed 2023-02-28
$405.98M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$42.24M
10-Q · filed 2022-05-10
$40.50M
10-Q · filed 2021-05-07
$85.79M
derived: sum of 2 quarters · filed 2023-02-28
$125.42M
derived: sum of 3 quarters · filed 2023-02-28
$197.21M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$43.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$83.18M
derived: sum of 2 quarters · filed 2023-02-28
$154.97M
derived: sum of 3 quarters · filed 2023-02-28
$193.55M
10-K · filed 2023-02-28
$153.51M
10-K · filed 2021-02-26
2020-09-30$39.63M
10-Q · filed 2022-02-18
$111.42M
derived: sum of 2 quarters · filed 2022-02-18
$150.00M
10-Q · filed 2022-02-18
$110.00M
10-Q · filed 2020-11-05
$225.67M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$71.79M
10-Q/A · filed 2022-02-18
$31.80M
10-Q · filed 2020-08-06
$110.37M
10-Q/A · filed 2022-02-18
$70.39M
10-Q · filed 2020-08-06
$186.04M
derived: sum of 3 quarters · filed 2022-03-01
$213.60M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$38.58M
10-Q · filed 2021-05-07
$114.25M
derived: sum of 2 quarters · filed 2022-03-01
$141.81M
derived: sum of 3 quarters · filed 2022-03-01
$162.66M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$75.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$103.23M
derived: sum of 2 quarters · filed 2022-03-01
$124.08M
derived: sum of 3 quarters · filed 2022-03-01
$135.72M
10-K · filed 2022-03-01
$103.62M
10-K/A · filed 2020-03-30
2019-09-30$27.56M
10-Q · filed 2020-11-05
$48.41M
derived: sum of 2 quarters · filed 2020-11-05
$60.05M
10-Q · filed 2020-11-05
2019-06-30$20.85M
10-Q · filed 2020-08-06
$32.53M
10-Q · filed 2020-08-06
2019-03-31$11.68M
10-Q · filed 2020-05-08
2018-12-31$26.66M
10-K · filed 2021-02-26
$27.55M
10-K/A · filed 2020-03-30
2017-12-31$7.70M
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87